Increased levels of AAT are seen in which type of tumor?

Alpha-1 antitrypsin (AAT) is a protein produced by the liver that plays a crucial role in protecting tissues from enzymes of inflammatory cells, particularly elastase. In the context of tumors, AAT levels can serve as a tumor marker and are often elevated in certain liver-related malignancies.

Hepatocellular carcinoma, being a primary liver cancer, is notably associated with elevated levels of AAT. Liver tumors can disrupt the normal processing and secretion of proteins, leading to increased synthesis of AAT in response to inflammation or damage within the liver itself. This elevation can occur in various liver diseases, including cirrhosis and chronic hepatic inflammation, and is particularly pronounced in hepatocellular carcinoma due to the increased production by tumor cells and the liver's acute phase response to cancer.

In contrast, other types of carcinomas, such as colorectal, pulmonary, and prostate cancers, do not typically show such a significant association with AAT elevation. While they may also lead to changes in various serum proteins, AAT is more specifically linked to liver pathology and hepatocellular carcinoma, making it a relevant marker in this specific context.